Gelonghui, Feb. 23 | Yahong Pharmaceutical (688176.SH) announced its 2023 annual performance report. During the reporting period, the company achieved operating income of 13.7533 million yuan; net profit attributable to owners of the parent company was -400 million yuan, with net loss increasing year-on-year; net profit attributable to owners of the parent company after deducting non-recurring profit and loss was -432.5 million yuan, with net loss increasing year-on-year after deduction.
亚虹医药(688176.SH)业绩快报：2023年度净亏损4.00亿元
Yahong Pharmaceutical (688176.SH) Performance Report: Net loss of 400 million yuan in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.